Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twenty-One Years of Insights From A Single-Center Living Kidney Donation Program.

Transplantation proceedings·2026
Same author

Vascular Complications Following Kidney Transplantation From Uncontrolled Donation After Circulatory Death: A Prospective Study.

Clinical transplantation·2025
Same author

Increased serum phosphate concentration within the normal reference levels is associated with all-cause mortality in non-dialysis CKD patients: A five-year prospective cohort study.

Nefrologia·2025
Same author

Long-Term Peritoneal Dialysis in Hereditary Transthyretin Amyloidosis: A Case Report and Management Challenges.

Cureus·2025
Same author

Evaluation of an Antibiotic Strategy for Ureteral Stent Removal After Kidney Transplant.

European urology open science·2025
Same author

Corrigendum: Preservation Fluid Bacteriology in Kidney Transplantation: Comparing Uncontrolled Donation After Circulatory Death With Donation After Brain Death.

Transplant international : official journal of the European Society for Organ Transplantation·2025

Related Experiment Video

Updated: Jul 3, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

[Lupus nephritis treatment].

Carla Santos-Araújo1, Manuel Pestana

  • 1Serviço de Nefrologia, Hospital de S. João/Faculdade de Medicina do Porto, Porto.

Acta Medica Portuguesa
|August 5, 2008
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) causes significant mortality, with lupus nephritis affecting 60% of patients and predicting poor outcomes. Diffuse proliferative lupus nephritis (Class IV) often leads to end-stage renal failure despite current therapies.

Related Experiment Videos

Last Updated: Jul 3, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease with high morbidity and mortality.
  • Lupus nephritis, affecting 60% of SLE patients, is a major predictor of renal impairment and overall mortality.
  • Renal biopsy is crucial for diagnosing and managing lupus nephritis, with Class IV (diffuse proliferative) being the most severe form.

Purpose of the Study:

  • To highlight the challenges in managing lupus nephritis, particularly Class IV.
  • To discuss the limitations of current therapeutic strategies for lupus nephritis.
  • To emphasize the need for improved treatment approaches for SLE patients with renal involvement.

Main Methods:

  • Review of existing literature on lupus nephritis classification and treatment outcomes.
  • Analysis of histological grading systems for lupus nephritis, focusing on Class IV.
  • Evaluation of the efficacy and adverse effects of current therapies like corticosteroids and cyclophosphamide.

Main Results:

  • Diffuse proliferative lupus nephritis (Class IV) is associated with a high risk of end-stage renal failure.
  • Current treatments, including corticosteroids and cyclophosphamide, show incomplete response rates in a significant number of patients.
  • Therapeutic interventions can lead to severe adverse events, including infertility and increased infection susceptibility.

Conclusions:

  • Lupus nephritis, especially Class IV, remains a critical determinant of patient prognosis in SLE.
  • Despite advancements, current therapies for lupus nephritis are suboptimal, necessitating further research.
  • Balancing treatment efficacy with adverse event management is essential for improving outcomes in lupus nephritis patients.